Literature DB >> 22330722

Epigenetic programming of neurodegenerative diseases by an adverse environment.

Olena Babenko1, Igor Kovalchuk, Gerlinde A Metz.   

Abstract

Experience and environment can critically influence the risk and progression of neurodegenerative disorders. Epigenetic mechanisms, such as miRNA expression, DNA methylation, and histone modifications, readily respond to experience and environmental factors. Here we propose that epigenetic regulation of gene expression and environmental modulation thereof may play a key role in the onset and course of common neurological conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis. For example, epigenetic mechanisms may mediate long-term responses to adverse experience, such as stress, to affect disease susceptibility and the course of neurodegenerative events. This review introduces the epigenetic components and their possible role in mediating neuropathological processes in response to stress. We argue that epigenetic modifications will affect neurodegenerative events through altered gene function. The study of epigenetic states in neurodegenerative diseases presents an opportunity to gain new insights into risk factors and pathogenic mechanisms. Moreover, research into epigenetic regulation of disease may revolutionize health care by opening new avenues of personalized, preventive and curative medicine.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330722     DOI: 10.1016/j.brainres.2012.01.038

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

1.  Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.

Authors:  Mireia Guerau-de-Arellano; Yue Liu; Walter H Meisen; David Pitt; Michael K Racke; Amy E Lovett-Racke
Journal:  J Autoimmune Disord       Date:  2015

2.  The Role of Histone Deacetylase 6 in Synaptic Plasticity and Memory.

Authors:  Sarah Perry; Beril Kiragasi; Dion Dickman; Anandasankar Ray
Journal:  Cell Rep       Date:  2017-02-07       Impact factor: 9.423

Review 3.  Epigenetic effects of green tea polyphenols in cancer.

Authors:  Susanne M Henning; Piwen Wang; Catherine L Carpenter; David Heber
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

4.  Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins.

Authors:  Xueli Zhang; Chongzhao Ran
Journal:  Curr Org Chem       Date:  2013-03-01       Impact factor: 2.180

Review 5.  Environmental factors in the development and progression of late-onset Alzheimer's disease.

Authors:  Moses N Wainaina; Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

6.  Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities.

Authors:  Sheila K Pirooznia; Felice Elefant
Journal:  Front Cell Neurosci       Date:  2013-03-28       Impact factor: 5.505

7.  MicroRNA-mediated regulation of target genes in several brain regions is correlated to both microRNA-targeting-specific promoter methylation and differential microRNA expression.

Authors:  Y-H Taguchi
Journal:  BioData Min       Date:  2013-05-31       Impact factor: 2.522

Review 8.  Oxidative stress in genetic mouse models of Parkinson's disease.

Authors:  Mustafa Varçin; Eduard Bentea; Yvette Michotte; Sophie Sarre
Journal:  Oxid Med Cell Longev       Date:  2012-07-08       Impact factor: 6.543

9.  The secret language of destiny: stress imprinting and transgenerational origins of disease.

Authors:  Fabiola C R Zucchi; Youli Yao; Gerlinde A Metz
Journal:  Front Genet       Date:  2012-06-04       Impact factor: 4.599

10.  Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring.

Authors:  Fabiola C R Zucchi; Youli Yao; Isaac D Ward; Yaroslav Ilnytskyy; David M Olson; Karen Benzies; Igor Kovalchuk; Olga Kovalchuk; Gerlinde A S Metz
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.